Digital Therapeutics Market is Projected to Reach CAGR of 31.6% by 2027- Exclusive Report by MarketsandMarkets™


 

The global digital therapeutics market is projected to reach USD 17.7 billion by 2027 from USD 4.5 billion in 2022, at a CAGR of 31.6% during the forecast period. Increasing prevalence of chronic diseases, developments in digital therapeutics to curb growing healthcare costs and government initiatives to support the digital therapeutics are driving the market growth.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=51646724

Browse in-depth TOC on "Digital Therapeutics (DTx) Market"

190 - Tables
33 - Figures
231 - Pages

Key Market Players

The digital therapeutics market is a highly diversified and competitive market, with several emerging players. The prominent players in this market include are Noom, Inc (US), Teladoc Health, Inc. (US), Omada Health, Inc. (US), WellDoc, Inc (US), Pear Therapeutics, Inc. (US), CogniFit Inc (US), Ginger (US), Propeller Health (US), 2Morrow, Inc. (US), Canary Health (US), Click Therapeutics, Inc. (US), Akili, Inc. (US), Cognoa, Inc (US), Wellthy Therapeutics Pvt. Ltd. (India), Twill Inc. (US), Better Therapeutics, Inc (US), Mindstrong (US), Kaia Health (Germany), BehaVR Inc (US), Ayogo (Canada), Mindable Health GmbH (Germany), Virta Health Corp (US), Hinge Health, Inc. (US), Orexo AB (Sweden) and Freespira (US).The players in the market focus on providing effective products to cater to the unmet needs of customers, increase profitability, and gain a competitive edge in the market.

Noom, Inc. (US) is among the world leaders digital therapeutics market in providing high-quality solutions for weight management, diabetes prevention, and stress reduction. Noom has been awarded multiple grants from the National Institutes of Health and provided the first mobile application recognized by the US CDC as a certified diabetes prevention program. In October 2021, Noom, Inc. launched a program called Noom Mood to expand its behavioral change approach to other conditions, including diabetes, hypertension, and sleep. The company is present in New York (US), Berlin (Germany), Seoul (South Korea), and Tokyo (Japan).

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=51646724

Teladoc Health, Inc. (US) is one of the prominent players digital therapeutics market. The company uses proprietary health signals and personalized interactions to improve health outcomes. It mainly targets diabetes, hypertension, weight management, diabetes prevention, and mental health. In February 2022, Teladoc Health, Inc. launched the Chronic Care Complete program, a chronic condition management solution to help individuals improve their health outcomes while living with multiple chronic conditions. Its programs, such as Chronic Care Complete and myStrength, have been accelerated by the 2020 merger with Livongo, further developing Teladoc Health’s ability to deliver true whole-person care with fully integrated clinical and digital solutions responsive to market needs. The merger between Teladoc and Livongo is one of the most significant integrations of competencies and skills in digital health.

Omada Health, Inc (US)  is one of the leading player digital therapeutics market. The company provides integrated, virtual care across chronic conditions, a top clinical need for employers and health plans. In June 2019, the company secured USD 73 million from its investors to develop digital care health programs focusing on preventable chronic conditions. The company is focusing on broadening its product offerings beyond diabetes—in April 2021, the company launched the Physician-guided Care Program, a virtual cardiometabolic clinic for hypertension and diabetes patients. The company also partners with many employers, payers, healthcare systems, and pharma companies.

North America commanded the largest share of the digital therapeutics market in 2021.

In 2021, North America held the largest share of the market, followed by Europe. The market in North America is also expected to grow at the highest CAGR. Factors such as the increasing investments in digital therapeutics, gradually improving reimbursement structures for digital therapeutics solutions drive market growth in this region.

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=51646724

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/digital-therapeutics-market.asp
Visit Our Website: https://www.marketsandmarkets.com/
Content Source: https://www.marketsandmarkets.com/PressReleases/digital-therapeutics.asp

Comments

Post a Comment

Popular posts from this blog

Human Microbiome Market Forecast 2025–2031: Driving Healthcare Innovation

Image
  Why the Human Microbiome Matters in 2025 The human microbiome —the trillions of microorganisms living inside the human body—is no longer just a topic for researchers. In 2025, it stands at the center of healthcare innovation , reshaping how we approach precision medicine, gut health, and therapeutic development . From microbiome-based therapies to diagnostics and probiotics, this rapidly expanding sector is capturing the attention of investors, biotech firms, and healthcare providers worldwide . According to the latest market research, the global human microbiome market, valued at US$0.91 billion in 2024, rose to US$1.40 billion in 2025 . It is projected to advance at a remarkable CAGR of 31.0% from 2025 to 2031 , culminating in an estimated US$7.09 billion by 2031 . This explosive growth highlights the increasing relevance of microbiome research in shaping the future of medicine . Download PDF Brochure:  Market Growth Insights & Trends The human microbiome ma...
Read more

Endoscopy Equipment Market Set to Reach USD 53.54 Billion by 2030 | Key Trends, Growth Drivers & Forecast

Image
  The global endoscopy equipment market is on a strong growth trajectory, projected to reach USD 53.54 billion by 2030 , up from USD 37.08 billion in 2025 , registering a CAGR of 7.6% (2025–2030). According to the latest MarketsandMarkets™ report , this surge is fueled by rising demand for minimally invasive procedures , rapid advancements in robot-assisted and AI-integrated endoscopy systems , and increasing day-care and outpatient surgical volumes worldwide. Market Overview: Why Endoscopy Equipment Demand Is Rising The endoscopy devices market has witnessed significant innovation in recent years. Growing cases of gastrointestinal (GI), pulmonary, and urological disorders are driving procedural volumes across hospitals and ambulatory surgical centers (ASCs). Key factors fueling market growth include: Rising patient preference for minimally invasive surgeries (MIS) that reduce pain, hospital stay, and recovery time. Increased adoption of disposable...
Read more

Empty Capsules Market Trends and Competitive Analysis - Exclusive Report by MarketsandMarkets™

Image
  The newly released exclusive study titled "Empty Capsules Market" guarantees that you will be better informed than your competitors. This study provides a comprehensive perspective of the market along with in-depth market insight and analysis that makes survival and success in the market easier. The market report presents the best market and business solutions for the Compound Management industry in this increasingly revolutionary market. Browse and in-depth TOC on "Empty Capsules Market" 176 - Tables 40 - Figures 216 - Pages Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=218018190 According to the new market research report "Empty Capsules Market is projected to reach USD 3.7 billion by 2026 from USD 2.6 billion in 2021, at a CAGR of 7.2% during the forecast period. Some of the Leading Players in the Empty Capsules Market The prominent players operating in the Empty Capsules Market are Capsugel (US), ACG World...
Read more